FDA Failures During Heparin Crisis Drive Congress’ Stronger Drug Safety Push

FDA's role in the handling of contaminated-heparin crisis is illustrative of "the best and the worst" of its performance under the administration, said David Nelson, senior investigator for the House Energy and Commerce Committee

More from Archive

More from Pink Sheet